‘Google’ for biomedical data could improve our understanding of diseases, improve treatments

pleviritis b
Image: ScienceSource/Roy Scott

If we aggregated all the data from countless years of research, might we learn something new about ourselves, the diseases that infect us, and possible treatments?

That’s the hope behind the Biomedical Data Translator program, launched by the NIH in 2016: to create a “Google” for biomedical data that could sift through hundreds of separate data sources to help researchers connect “dots” in datasets with distinct formats and peculiarities. 

The program has awarded about $17.5 million to 19 institutions across the country that are working to integrate years of data, ranging from electronic health records to genomic sequences, that had previously been spread across a variety of platforms, and then applying new machine learning tools to help organize and reason through the wealth of information.

This means that, unlike Google, the Translator would be able to make connections between datasets that had not previously been associated with each other. 

The goals of this program are ambitious, including to show “every disease that has symptom X and/or affects a particular cell type,” but those involved remain steadfast in their hope to make lasting change in the way patients are treated. 

Read full, orignal post: NIH-funded project aims to build a ‘Google’ for biomedical data

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.